+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Artificial Pancreas Device System Market Research Report by Device Type, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4904638
  • Report
  • July 2021
  • Region: Global
  • 189 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Artificial Pancreas Device System Market will Grow to USD 428.37 Million by 2026, at a CAGR of 19.81%

FEATURED COMPANIES

  • Animas Corporation
  • Beta Bionics
  • Bigfoot Biomedical
  • Defymed
  • Insulet Corporation
  • Johnson & Johnson
The Global Artificial Pancreas Device System Market size was estimated at USD 144.77 Million in 2020 and expected to reach USD 172.97 Million in 2021, at a Compound Annual Growth Rate (CAGR) 19.81% to reach USD 428.37 Million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Artificial Pancreas Device System to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Device Type, the Artificial Pancreas Device System Market was studied across Control-to-Range System, Control-to-Target System, and Threshold Suspended Device System.
  • Based on Treatment Type, the Artificial Pancreas Device System Market was studied across Bi-hormonal, Hybrid, and Insulin Only.
  • Based on End User, the Artificial Pancreas Device System Market was studied across Hospitals and Research Institute.
  • Based on Region, the Artificial Pancreas Device System Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Artificial Pancreas Device System Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Artificial Pancreas Device System Market, including Animas Corporation, Beta Bionics, Bigfoot Biomedical, Defymed, Insulet Corporation, Johnson & Johnson, Medtronic plc, Semma Therapeutics, Tandem Diabetes Care, and TypeZero Technologies.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Artificial Pancreas Device System Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Artificial Pancreas Device System Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Artificial Pancreas Device System Market?
4. What is the competitive strategic window for opportunities in the Global Artificial Pancreas Device System Market?
5. What are the technology trends and regulatory frameworks in the Global Artificial Pancreas Device System Market?
6. What is the market share of the leading vendors in the Global Artificial Pancreas Device System Market?
7. What modes and strategic moves are considered suitable for entering the Global Artificial Pancreas Device System Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Animas Corporation
  • Beta Bionics
  • Bigfoot Biomedical
  • Defymed
  • Insulet Corporation
  • Johnson & Johnson
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Device Type Outlook
3.4. Treatment Type Outlook
3.5. End User Outlook
3.6. Region Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of diabetes due to changing lifestyle and elderly population
5.1.1.2. Increase in disposable income and awareness on options to manage diabetes
5.1.1.3. Prevalence of pancreatic cancer and demand for automated systems for glycemic control
5.1.2. Restraints
5.1.2.1. Inability of the system to treat athletic diabetes
5.1.3. Opportunities
5.1.3.1. Growing investments in research and development in the field
5.1.3.2. Availability of funds from the governments and organizations to improve the quality of treatment
5.1.4. Challenges
5.1.4.1. Awareness of the side effects of the treatment
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Artificial Pancreas Device System Market, by Device Type
6.1. Introduction
6.2. Control-to-Range System
6.3. Control-to-Target System
6.4. Threshold Suspended Device System

7. Artificial Pancreas Device System Market, by Treatment Type
7.1. Introduction
7.2. Bi-hormonal
7.3. Hybrid
7.4. Insulin Only

8. Artificial Pancreas Device System Market, by End User
8.1. Introduction
8.2. Hospitals
8.3. Research Institute

9. Americas Artificial Pancreas Device System Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Artificial Pancreas Device System Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Thailand

11. Europe, Middle East & Africa Artificial Pancreas Device System Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Animas Corporation
13.2. Beta Bionics
13.3. Bigfoot Biomedical
13.4. Defymed
13.5. Insulet Corporation
13.6. Johnson & Johnson
13.7. Medtronic plc
13.8. Semma Therapeutics
13.9. Tandem Diabetes Care
13.10. TypeZero Technologies

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2020 (USD MILLION)
FIGURE 3. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2020 (USD MILLION)
FIGURE 4. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 5. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY REGION, 2020 (USD MILLION)
FIGURE 6. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 7. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET: MARKET DYNAMICS
FIGURE 8. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 9. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2020 VS 2026 (%)
FIGURE 10. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2026
FIGURE 12. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL-TO-RANGE SYSTEM, 2018-2026 (USD MILLION)
FIGURE 13. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL-TO-RANGE SYSTEM, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 14. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL-TO-TARGET SYSTEM, 2018-2026 (USD MILLION)
FIGURE 15. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL-TO-TARGET SYSTEM, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 16. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY THRESHOLD SUSPENDED DEVICE SYSTEM, 2018-2026 (USD MILLION)
FIGURE 17. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY THRESHOLD SUSPENDED DEVICE SYSTEM, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 18. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2020 VS 2026 (%)
FIGURE 19. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2026
FIGURE 21. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY BI-HORMONAL, 2018-2026 (USD MILLION)
FIGURE 22. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY BI-HORMONAL, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 23. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HYBRID, 2018-2026 (USD MILLION)
FIGURE 24. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HYBRID, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 25. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN ONLY, 2018-2026 (USD MILLION)
FIGURE 26. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN ONLY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 27. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 28. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2026
FIGURE 30. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2026 (USD MILLION)
FIGURE 31. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 32. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY RESEARCH INSTITUTE, 2018-2026 (USD MILLION)
FIGURE 33. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 34. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 35. ARGENTINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 36. BRAZIL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 37. CANADA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 38. MEXICO ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 39. UNITED STATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 40. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 41. AUSTRALIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 42. CHINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 43. INDIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 44. INDONESIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 45. JAPAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 46. MALAYSIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 47. PHILIPPINES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 48. SINGAPORE ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 49. SOUTH KOREA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 50. THAILAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 51. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 52. FRANCE ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 53. GERMANY ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 54. ITALY ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 55. NETHERLANDS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 56. QATAR ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 57. RUSSIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 58. SAUDI ARABIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 59. SOUTH AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 60. SPAIN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 61. UNITED ARAB EMIRATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 62. UNITED KINGDOM ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 63. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET: FPNV POSITIONING MATRIX
FIGURE 64. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 65. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL-TO-RANGE SYSTEM, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL-TO-TARGET SYSTEM, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY THRESHOLD SUSPENDED DEVICE SYSTEM, BY REGION, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY BI-HORMONAL, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HYBRID, BY REGION, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN ONLY, BY REGION, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2018-2026 (USD MILLION)
TABLE 15. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 16. ARGENTINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 17. BRAZIL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 18. CANADA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 19. MEXICO ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 20. UNITED STATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 21. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 22. AUSTRALIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 23. CHINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 24. INDIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 25. INDONESIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 26. JAPAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. MALAYSIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 28. PHILIPPINES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 29. SINGAPORE ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 30. SOUTH KOREA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 31. THAILAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. FRANCE ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. GERMANY ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. ITALY ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. NETHERLANDS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. QATAR ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. RUSSIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. SAUDI ARABIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 40. SOUTH AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 41. SPAIN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 42. UNITED ARAB EMIRATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 43. UNITED KINGDOM ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 44. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET: SCORES
TABLE 45. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET: BUSINESS STRATEGY
TABLE 46. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET: PRODUCT SATISFACTION
TABLE 47. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET: RANKING
TABLE 48. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 49. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET: MERGER & ACQUISITION
TABLE 50. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 51. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 52. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET: INVESTMENT & FUNDING
TABLE 53. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 54. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Animas Corporation
  • Beta Bionics
  • Bigfoot Biomedical
  • Defymed
  • Insulet Corporation
  • Johnson & Johnson
  • Medtronic plc
  • Semma Therapeutics
  • Tandem Diabetes Care
  • TypeZero Technologies
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll